PKD1 and autosomal dominant disease: In contrast to most ADPKD mouse models, which utilize Pkd1-/- null mutants, we explore these mechanisms using a Pkd1 heterozygous genetic model, which could more accurately reflect the aberrant epigenetic regulatory mechanisms that facilitate progression of autosomal dominant disease in humans.48